Flavio Luciano Ribichini

Complex calcified lesion: LIVE Educational Case from Leipzig Heart Centre - Leipzig, Germany

22 May 2026 – From EuroPCR 2026

This session from Leipzig Heart Centre offers an in-depth exploration of complex calcified coronary lesions. It covers the challenges in managing these lesions, emphasizes effective preparation strategies, and highlights the essential role of intravascular imaging. The session includes patient presentation, detailed imaging analysis, strategic operator planning,...

DCB as a key player in the management of complex coronary lesions

21 May 2026 – From EuroPCR 2026

This session highlights the pivotal role of drug-coated balloons (DCB) in managing complex coronary lesions. Experienced operators share their approaches to applying DCB in challenging clinical and anatomical settings, optimized by intravascular imaging guidance. The discussion includes insights from the LatamBif Registry and other series on...

Spectrum of cardiogenic shock

21 May 2026 – From EuroPCR 2026

This session delves into the broad spectrum of cardiogenic shock phenotypes, emphasizing the importance of selecting appropriate left ventricular support tailored to specific clinical scenarios. It offers critical insights into the timing of mechanical circulatory support and revascularisation strategies to optimize patient outcomes.

Identifying and planning protected temporary mechanical circulatory support-based procedures in high-risk patients

21 May 2026 – From EuroPCR 2026

This session provides an in-depth update on protected temporary mechanical circulatory support-based procedures in high-risk cardiac patients. It covers patient identification criteria, device selection, and multidisciplinary planning to optimize outcomes in protected PCI, ventricular ablation, and surgical contexts.

Renal denervation 360°: are you ready for the future?

20 May 2026 – From EuroPCR 2026

Where does renal denervation (RDN) stand today, and where is it heading next?

This EuroPCR 2026 session provides a comprehensive update on RDN, covering its safe and effective use in line with the latest European recommendations. Faculty members share practical guidance on patient selection, programme implementation, and...

Renal denervation 360°: are you ready for the future?

IBERIS: the first radial renal denervation (RDN) system for the treatment of uncontrolled hypertension

20 May 2026 – From EuroPCR 2026

This session introduces the IBERIS system, the first radial-access platform for renal denervation in patients with uncontrolled hypertension. It covers patient selection, procedural planning, and key technical considerations for both transfemoral and transradial approaches. A LIVE case demonstration highlights essential procedural steps while addressing the clinical...

IBERIS: the first radial renal denervation (RDN) system for the treatment of uncontrolled hypertension

Interventions for hypertension: latest developments

20 May 2026 – From EuroPCR 2026

This session reviews the latest developments in interventional treatments for hypertension, focusing on renal denervation (RDN) technologies and clinical outcomes. It includes comparative procedural data from global registries and studies, novel computational assessments, and applications in specific patient populations such as those with polycystic kidney disease...

New data in DCB outcomes

20 May 2026 – From EuroPCR 2026

Explore emerging evidence on drug-coated balloon (DCB) outcomes, featuring intravascular lithotripsy combined with DCB in calcified small vessels, OCT-guided PCI registries, predictors of angiographic success post-sirolimus-coated balloon angioplasty, and clinical impact in multivessel coronary artery disease management.

DCB in contemporary PCI: evidence, technique and physiology-guided decision-making

19 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores the evolving role of drug-coated balloons (DCB) in contemporary PCI, highlighting how growing clinical evidence, refined procedural strategies and physiology-guided tools are reshaping everyday practice.

The discussion reviews the latest data supporting DCB use, including long-term outcomes from major registries and trials...

DCB in contemporary PCI: evidence, technique and physiology-guided decision-making

Interventional therapy for hypertension

19 May 2026 – From EuroPCR 2026

This session addresses interventional therapies for hypertension, emphasizing patient selection for renal denervation and integration of this technique within comprehensive hypertension management. It also reviews available renal denervation technologies, optimal procedural approaches, and considerations for interventional treatment of renal artery stenosis.

Structural and valvular innovations

19 May 2026 – From EuroPCR 2026

This session highlights the latest innovations in structural and valvular cardiology, featuring novel technologies such as a new self-expandable transcatheter aortic valve for aortic stenosis treatment and a temporary atrioventricular sequential pacing system. It also discusses non-clinical testing methodologies supporting U.S. market approvals, non-invasive ultrasound therapy...

Rapid fire session on vascular innovation, interventional technologies and hypertension

18 May 2026 – From EuroPCR 2026

This rapid fire session showcased cutting-edge innovations in vascular interventions, interventional technologies, and hypertension management. Highlights included three-dimensional OCT-guided ultrafast laser atherectomy for calcified lesions, a novel biodegradable metallic stent, intelligent pressure-controlled perfusion to prevent acute limb ischemia, a microneedle balloon catheter, personalized arterial hypertension control...

PCI for complex calcific coronary artery disease - LIVE Case

22 May 2025 – From EuroPCR 2025

An 87-year-old female patient, at high bleeding risk and with preserved LV function, presented 2 months ago with an inferior STEMI and multivessel disease. She initially underwent RCA PCI followed by staged LCx PCI. She was now referred for PCI of a long, heavily calcified lesion...

PCI for complex calcific coronary artery disease - LIVE Case

Innovations in transcatheter aortic valve devices and techniques

22 May 2025 – From EuroPCR 2025

Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...

Innovations in transcatheter aortic valve devices and techniques

Simplify PCI! Know where and how to win with drug-coated balloon

22 May 2025 – From EuroPCR 2025

This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into...

Simplify PCI! Know where and how to win with drug-coated balloon

Hypertension interventions in specific scenarios

22 May 2025 – From EuroPCR 2025

Explore interventions for hypertension in specific patient populations, including renal artery stenosis treatment and the role of renal denervation. Discuss multidisciplinary approaches and evidence supporting renal denervation in advanced kidney disease, heart failure, and young patients.